Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGEF7 intronic transcript 1 (ARHGEF7-IT1) is a long non-coding RNA (lncRNA) transcript derived from the intronic sequence of the ARHGEF7 gene[2][5]. Unlike the ARHGEF7 protein-coding gene, which functions as a Rho guanine nucleotide exchange factor, ARHGEF7-IT1 is not predicted to produce a functional protein and currently lacks known biological function, pathway involvement, or recognized disease relevance. It is annotated as a non-coding RNA in genomic databases, and there are no documented drug interactions or established use as a biomarker or therapeutic target at present[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARHGEF7 intronic transcript 1 (ARHGEF7-IT1).